| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 70700-301-01 | 70700-301 | HUMAN PRESCRIPTION DRUG | Guanfacine Hydrochloride | Guanfacine Hydrochloride | TABLET | ORAL | 20240224 | N/A | ANDA | ANDA218326 | XIROMED, LLC | GUANFACINE HYDROCHLORIDE | 1 mg/1 | 100 TABLET in 1 BOTTLE (70700-301-01) |
| 70700-301-30 | 70700-301 | HUMAN PRESCRIPTION DRUG | Guanfacine Hydrochloride | Guanfacine Hydrochloride | TABLET | ORAL | 20240224 | N/A | ANDA | ANDA218326 | XIROMED, LLC | GUANFACINE HYDROCHLORIDE | 1 mg/1 | 30 TABLET in 1 BOTTLE (70700-301-30) |
| 70700-302-01 | 70700-302 | HUMAN PRESCRIPTION DRUG | Guanfacine Hydrochloride | Guanfacine Hydrochloride | TABLET | ORAL | 20240224 | N/A | ANDA | ANDA218326 | XIROMED, LLC | GUANFACINE HYDROCHLORIDE | 2 mg/1 | 100 TABLET in 1 BOTTLE (70700-302-01) |
| 70700-302-05 | 70700-302 | HUMAN PRESCRIPTION DRUG | Guanfacine Hydrochloride | Guanfacine Hydrochloride | TABLET | ORAL | 20240224 | N/A | ANDA | ANDA218326 | XIROMED, LLC | GUANFACINE HYDROCHLORIDE | 2 mg/1 | 500 TABLET in 1 BOTTLE (70700-302-05) |
| 70700-302-30 | 70700-302 | HUMAN PRESCRIPTION DRUG | Guanfacine Hydrochloride | Guanfacine Hydrochloride | TABLET | ORAL | 20240224 | N/A | ANDA | ANDA218326 | XIROMED, LLC | GUANFACINE HYDROCHLORIDE | 2 mg/1 | 30 TABLET in 1 BOTTLE (70700-302-30) |